TI
GMAB icon

Trexquant Investment’s Genmab GMAB Stock Holding History

Trexquant Investment’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,735
Closed -$667K – 1715
2025
Q3 		$667K Sell
21,735
-341,379
-94% -$8.32M 0.01% 1255
2025
Q2 		$7.5M Sell
363,114
-104,071
-22% -$2.14M 0.08% 374
2025
Q1 		$9.15M Buy
467,185
+87,249
+23% +$1.83M 0.11% 285
2024
Q4 		$7.93M Buy
379,936
+316,089
+495% +$6.94M 0.09% 350
2024
Q3 		$1.56M Buy
63,847
+52,334
+455% +$1.4M 0.02% 898
2024
Q2 		$289K Sell
11,513
-55,600
-83% -$1.58M ﹤0.01% 1373
2024
Q1 		$2.01M Sell
67,113
-85,985
-56% -$2.53M 0.04% 652
2023
Q4 		$4.87M Buy
+153,098
New +$4.81M 0.11% 256
2023
Q2 		– Sell
-30,974
Closed -$1.17M – 1562
2023
Q1 		$1.17M Sell
30,974
-76,312
-71% -$2.93M 0.03% 671
2022
Q4 		$4.55M Buy
107,286
+95,530
+813% +$3.94M 0.13% 206
2022
Q3 		$378K Buy
+11,756
New +$413K 0.01% 928
2022
Q2 		– Sell
-22,914
Closed -$829K – 1640
2022
Q1 		$829K Sell
22,914
-24,815
-52% -$852K 0.04% 551
2021
Q4 		$1.89M Buy
+47,729
New +$1.99M 0.12% 223
2021
Q2 		– Sell
-6,854
Closed -$225K – 1236
2021
Q1 		$225K Buy
+6,854
New +$258K 0.02% 914
2020
Q3 		– Sell
-22,274
Closed -$755K – 1320
2020
Q2 		$755K Buy
22,274
+3,051
+16% +$83.1K 0.05% 507
2020
Q1 		$407K Buy
+19,223
New +$429K 0.03% 737

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Trexquant Investment's GMAB Position: Q4 2025 in Review

Trexquant Investment sold out of Genmab (GMAB) in Q4 2025, closing a stake of 21,735 shares — an estimated $667K sold.

Trexquant Investment first reported a position in GMAB in Q1 2020 and held it in 16 quarters. The position peaked at $9.15M in Q1 2025. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • Trexquant Investment reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
  • Trexquant Investment sold 21,735 Genmab shares in Q4 2025, an estimated $667K.
  • Trexquant Investment first reported a position in Genmab in Q1 2020 and held it in 16 quarters.
  • Trexquant Investment's Genmab position peaked at $9.15M in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.